We observed an increasing trend in the prescribing of ambroxol, which emerged as the most frequently prescribed CCM among children aged 12–15.99 years in 2023.
← all excerpts
Cough medicine prescriptions for children by physician specialty and healthcare sector: a Finnish population-based nationwide register study.
1
—
—